Skip to main content
Aequs Limited logo

Aequs Limited — Investor Relations & Filings

Ticker · AEQUS ISIN · INE947N01017 LEI · 33580025YVC6YTQM7U03 BSE.NS Manufacturing
Open in API
Filings indexed 134 across all filing types
Latest filing 2026-01-29 Regulatory Filings
Country IN India
Listing BSE.NS AEQUS

About Aequs Limited

https://www.aequs.com

Aequs Limited is a diversified contract manufacturing partner specializing in precision engineering and manufacturing solutions. The company operates a vertically integrated ecosystem that provides end-to-end services, including forging, machining, surface treatment, and assembly. Its primary operations are centered around specialized manufacturing clusters, notably in the aerospace, toys, and consumer durable goods sectors. In the aerospace domain, the company supplies critical components and sub-assemblies to major global original equipment manufacturers. Aequs leverages advanced technology and a global supply chain to deliver high-quality components for complex engineering requirements. The company’s infrastructure supports large-scale production with a focus on operational efficiency and technical excellence across its diverse product portfolios.

Recent filings

Filing Released Lang Actions
Audio recording of Earnings Conference Call pertaining to the Unaudited Financial Results of the Company for the third quarter and nine months of the Financial Year 2025-26, ended December ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the audio recording of an Earnings Conference Call for the third quarter and nine months ended December 31, 2025. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which governs disclosure of material events. The document states that the audio recording is available on the company's website and requests the exchanges to take the information on record. The document itself does not contain the transcript or detailed financial data but is an announcement about the availability of the earnings call recording. Given the short length (1825 characters) and the nature of the content, this is not the full call transcript but an announcement related to it. According to the rules, announcements about reports or recordings are classified as Regulatory Filings (RNS) rather than Call Transcript (CT).
2026-01-29 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short communication addressed to stock exchanges regarding the availability of the audio recording of an Earnings Conference Call for the third quarter and nine months ended December 31, 2025. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which governs disclosures related to events like earnings calls. The document does not contain the transcript or detailed financial data but only informs about the availability of the audio recording on the company's website. Given the short length (1825 characters) and the nature of the content (announcement of availability of earnings call recording), this is not the actual Call Transcript (CT) but rather a Regulatory Filing (RNS) announcing the event and providing a link. Therefore, the appropriate classification is Regulatory Filings (RNS).
2026-01-29 English
Monitoring Agency Report issued by CARE Ratings Limited, for the quarter ended December 31, 2025, in respect of utilisation of proceeds of the Pre-Initial Public Offer Placement and Initial ....
Regulatory Filings Classification · 95% confidence The document is titled 'Monitoring Agency Report for the quarter ended December 31, 2025' and is submitted pursuant to SEBI regulations related to the utilization of proceeds from a Pre-Initial Public Offer Placement and Initial Public Offer. It contains detailed information on the monitoring of issue proceeds, including certifications, comments from the monitoring agency and the board, and financial details related to the IPO proceeds utilization. The document is a formal report issued by a monitoring agency (CARE Ratings Limited) and includes substantive financial and compliance data for a specific quarter. It is not an announcement of a report publication, nor is it a certification or a brief summary. The content aligns with a regulatory compliance report on the use of IPO proceeds, which fits best under the category of Regulatory Filings (RNS) as it is a regulatory submission under SEBI rules but does not fit into other more specific categories like Annual Report or Earnings Release. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2026-01-29 English
Monitoring Agency Report
Regulatory Filings Classification · 95% confidence The document is titled 'Monitoring Agency Report for the quarter ended December 31, 2025' and is submitted pursuant to SEBI regulations related to the utilization of proceeds from a Pre-Initial Public Offer Placement and Initial Public Offer. It contains detailed information on the monitoring of issue proceeds, including certifications, comments from the monitoring agency, and board of directors' comments. The report is comprehensive and includes financial details and compliance information for the quarter ending December 31, 2025. This fits the definition of a regulatory compliance report related to capital raising and utilization, but it is not a full annual or interim financial report. It is a standalone monitoring agency report required by regulatory authorities to ensure proper use of IPO proceeds. Therefore, it is best classified as a Regulatory Filing (RNS) because it is a regulatory compliance document that does not fit into other specific categories like Annual Report or Interim Report. The document length (15,000 characters) and content confirm it is the report itself, not just an announcement or certification.
2026-01-29 English
Financial Results For The Quarter & Nine Months Period Ended 31.12.2025
Regulatory Filings
2026-01-29 English
Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are herewith enclosing ....
Investor Presentation Classification · 95% confidence The document is titled 'Investor Presentation' and is addressed to stock exchanges referencing Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates disclosure of material events including investor presentations. The content includes detailed business overview, financial highlights for Q3 and 9M FY26, growth strategies, industry overview, and manufacturing capabilities. It explicitly states it is an 'Investor Presentation' on unaudited financial results for the third quarter and nine months ended December 31, 2025. The document length is substantial (15,000 characters), containing detailed financial and operational information, consistent with an investor presentation rather than a brief announcement or a full annual or quarterly report. There is no indication that this is a full Annual Report (10-K) or Interim Report (IR) with full financial statements, nor is it a regulatory filing or certification. Therefore, the document fits the category of an Investor Presentation (IP).
2026-01-29 English

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.